Federico Cirillo1, Leonora Grilli2, Camilla Ronchetti1,2, Ilaria Paladino2, Emanuela Morenghi3, Andrea Busnelli1,2, Paolo Emanuele Levi-Setti4,5. 1. Division of Gynecology and Reproductive Medicine, Department of Gynecology, Fertility Center, Humanitas Research Hospital, IRCCS, Via Manzoni 56, 20089, Rozzano, Milan, Italy. 2. Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4Pieve Emanuele, 20090, Milan, Italy. 3. Biostatistics Unit, Humanitas Research Hospital, IRCCS, 20089, Rozzano, Milan, Italy. 4. Division of Gynecology and Reproductive Medicine, Department of Gynecology, Fertility Center, Humanitas Research Hospital, IRCCS, Via Manzoni 56, 20089, Rozzano, Milan, Italy. paolo.levi_setti@humanitas.it. 5. Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4Pieve Emanuele, 20090, Milan, Italy. paolo.levi_setti@humanitas.it.
Abstract
PURPOSE: To assess whether live birth rates (LBR) and maternal/neonatal complications differed following single fresh and frozen-warmed blastocyst transfer. METHODS: The present retrospective observational study analyzed 4,613 single embryo transfers (SET) (646 fresh and 3,967 frozen) from January 1, 2014, to December 31, 2018. Fresh embryo transfer at blastocyst stage was considered according to the age of the patient and her prognosis. In case of the risk of ovarian hyperstimulation syndrome, premature progesterone rise, non-optimal endometrial growth, or supernumerary embryos, cryopreservation with subsequent frozen embryo transfer (FET) was indicated. RESULTS: No differences in LBR were recorded. Fresh embryo transfers yielded an increase both in neonatal complications OR 2.15 (95% CI 1.20-3.86, p 0.010), with a higher prevalence of singletons weighting below the 5th percentile (p 0.013) and of intrauterine growth retardation (p 0.015), as well as maternal complications, with a higher placenta previa occurrence OR 3.58 (95% CI 1.54-8.28, p 0.003), compared to FET. CONCLUSION: LBR appears not to be affected by the transfer procedure preferred. Fresh embryo transfer is associated with higher risk of neonatal complications (specifically a higher prevalence of singletons weighting below the 5th percentile and of intrauterine growth retardation) and placenta previa. Reflecting on the increased practice of ART procedures, it is imperative to understand whether a transfer procedure yields less complications than the other and if it is time to switch to a "freeze-all" procedure as standard practice. TRIAL REGISTRATION: Clinical Trial Registration Number: NCT04310761. Date of registration: March 17, 2020, retrospectively registered.
PURPOSE: To assess whether live birth rates (LBR) and maternal/neonatal complications differed following single fresh and frozen-warmed blastocyst transfer. METHODS: The present retrospective observational study analyzed 4,613 single embryo transfers (SET) (646 fresh and 3,967 frozen) from January 1, 2014, to December 31, 2018. Fresh embryo transfer at blastocyst stage was considered according to the age of the patient and her prognosis. In case of the risk of ovarian hyperstimulation syndrome, premature progesterone rise, non-optimal endometrial growth, or supernumerary embryos, cryopreservation with subsequent frozen embryo transfer (FET) was indicated. RESULTS: No differences in LBR were recorded. Fresh embryo transfers yielded an increase both in neonatal complications OR 2.15 (95% CI 1.20-3.86, p 0.010), with a higher prevalence of singletons weighting below the 5th percentile (p 0.013) and of intrauterine growth retardation (p 0.015), as well as maternal complications, with a higher placenta previa occurrence OR 3.58 (95% CI 1.54-8.28, p 0.003), compared to FET. CONCLUSION: LBR appears not to be affected by the transfer procedure preferred. Fresh embryo transfer is associated with higher risk of neonatal complications (specifically a higher prevalence of singletons weighting below the 5th percentile and of intrauterine growth retardation) and placenta previa. Reflecting on the increased practice of ART procedures, it is imperative to understand whether a transfer procedure yields less complications than the other and if it is time to switch to a "freeze-all" procedure as standard practice. TRIAL REGISTRATION: Clinical Trial Registration Number: NCT04310761. Date of registration: March 17, 2020, retrospectively registered.
Authors: Bruce S Shapiro; Said T Daneshmand; Forest C Garner; Martha Aguirre; Cynthia Hudson; Shyni Thomas Journal: Fertil Steril Date: 2011-07-06 Impact factor: 7.329
Authors: Filippo Maria Ubaldi; Danilo Cimadomo; Antonio Capalbo; Alberto Vaiarelli; Laura Buffo; Elisabetta Trabucco; Susanna Ferrero; Elena Albani; Laura Rienzi; Paolo E Levi Setti Journal: Fertil Steril Date: 2017-04-19 Impact factor: 7.329
Authors: Carolien M Boomsma; Annemieke Kavelaars; Marinus J C Eijkemans; Bart C J M Fauser; Cobi J Heijnen; Nick S Macklon Journal: Fertil Steril Date: 2009-12-11 Impact factor: 7.329
Authors: Fernando Zegers-Hochschild; G David Adamson; Silke Dyer; Catherine Racowsky; Jacques de Mouzon; Rebecca Sokol; Laura Rienzi; Arne Sunde; Lone Schmidt; Ian D Cooke; Joe Leigh Simpson; Sheryl van der Poel Journal: Fertil Steril Date: 2017-07-29 Impact factor: 7.329
Authors: Felipe C Dieamant; Claudia G Petersen; Ana L Mauri; V Comar; Mariana Mattila; Laura D Vagnini; Adriana Renzi; Bruna Petersen; Andreia Nicoletti; João Batista A Oliveira; Ricardo Lr Baruffi; Jose G Franco Journal: JBRA Assist Reprod Date: 2017-09-01